Published on 29 Jul 2023 on Simply Wall St. via Yahoo Finance
For many, the main point of investing is to generate higher returns than the overall market. But even the best stock picker will only win with some selections. At this point some shareholders may be questioning their investment in Daré Bioscience, Inc. (NASDAQ:DARE), since the last five years saw the share price fall 33%. And we doubt long term believers are the only worried holders, since the stock price has declined 33% over the last twelve months. The falls have accelerated recently, with the share price down 25% in the last three months.
With that in mind, it's worth seeing if the company's underlying fundamentals have been the driver of long term performance, or if there are some discrepancies.
View our latest analysis for Daré Bioscience